# A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients

> **NCT02862262** · NA · COMPLETED · sponsor: **Luminex Molecular Diagnostics** · enrollment: 1052 (actual)

## Conditions studied

- Bordetella Infections
- Bordetella Pertussis Infection
- Bordetella Parapertussis Infection

## Interventions

- **DEVICE:** ARIES Bordetella Assay

## Key facts

- **NCT ID:** NCT02862262
- **Lead sponsor:** Luminex Molecular Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2016-11
- **Final completion:** 2016-11-14
- **Target enrollment:** 1052 (ACTUAL)
- **Last updated:** 2018-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02862262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02862262, "A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02862262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*